🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07171593
Enrolling by invitation Not applicable

High-protein Oral Nutrition With HMB for Active CD Patients With Sarcopenia

NCT07171593 · tracked via the Priya Life Science China tracker
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Phase
Not applicable
Started
2024-03-04
Last updated
2025-09-12

Condition(s) studied

Handgrip Strength

Investigational drug(s) / intervention(s)

HMB

HMB: EEN+HMB

Study summary

The efficacy of B-hydroxy-β-methybutyrate in sarcopenia

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients with active Crohn's disease (CD) who visited the Sixth Affiliated Hospital of Sun Yat-sen University between July 2023 and December 2024; 2. Aged 18-50 years; 3. Complicated with sarcopenia; 4. Willing and able to tolerate oral exclusive enteral nutrition (EEN) therapy; 5. Signed informed consent and able to comply with the study procedures; 6. Colonic or ileocolonic type CD (SES-CD ≥6; if only terminal ileum is involved, SES-CD ≥4). Exclusion Criteria: 1. Short bowel syndrome; 2. High-output jejunal fistula; 3. Severe stress or shock status; 4. Complete mechanical intestinal obstruction, acute gastrointestinal bleeding, or severe intra-abdominal infection; 5. Severe hepatic, renal, or cardiac diseases, or malignant tumors; 6. History of allergy or contraindication to Ensure or HMB; 7. Persistent severe vomiting or intractable diarrhea; 8. Congenital disorders of sugar or amino acid metabolism; 9. Underwent CD-related intestinal surgery or received biologic therapy within the past month, or received immunosuppressive/antibiotic therapy related to CD within 2 weeks prior to enrollment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sixth Hospital Affiliated to Sun Yat-sen University Guangzhou Guangdong

More Sixth Affiliated Hospital, Sun Yat-sen University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07171593 on ClinicalTrials.gov ↗ ← All trials in China